Skip to content
The News Caravan
Most Authentic News Portal
Primary Navigation Menu
Menu
  • Home
  • International
  • Kashmir
  • National
  • Education
  • ShoppingShopping News & Deals – The News Caravan Stay updated with the latest shopping trends, exclusive deals, and expert reviews. From fashion to tech, we bring you the hottest discounts, price comparisons, and shopping insights. Shop smarter with The News Caravan!
  • Entertainment
  • OpinionWrite For Us Interesting in writing for TheNewsCaravan ? From opinion pieces to features, from interviews with legends to stories for the kids, TheNewsCaravan offers space to all right kind of ideas that have the potential of stirring imagination and bringing chance. To explore more, drop in an email to the editor at thenewscaravan@gmail.com or info@thenewscaravan.com
  • Press Release
  • About Us – The News Caravan
  • 📰 Advertise with The News Caravan – Reach 15,000+ Monthly Readers
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Submit Guest post
  • Terms and Conditions

SII

Current COVID strain mild, SII producing 5-6million Covovax doses: Adar Poonawalla

Current COVID strain mild, SII producing 5-6million Covovax doses: Adar Poonawalla

2023-04-22
National
By: SAQIB SHAFI
On: April 22, 2023

[ad_1] Pune: The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company’s chief executive officer Adar Poonawalla on Saturday. Poonawalla was talking to media persons amid rising cases of coronavirus infections inContinue Reading

Oxford University, SII tie-up delivers ‘high efficacy’ malaria vaccine

Oxford University, SII tie-up delivers ‘high efficacy’ malaria vaccine

2023-04-13
National
By: SAQIB SHAFI
On: April 13, 2023

[ad_1] London: A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up “high efficacy” malaria vaccine has been licensed for use in Ghana by Africa’s Food and Drugs Authority, the university announced here on Thursday. The R21/Matrix-M vaccine, leveraging Novavax’s adjuvant technology, has been approvedContinue Reading

Designed using Magazine Lume. Powered by WordPress. © 2026